SE449816B - Vattenfri spermiedodande komposition - Google Patents

Vattenfri spermiedodande komposition

Info

Publication number
SE449816B
SE449816B SE8103833A SE8103833A SE449816B SE 449816 B SE449816 B SE 449816B SE 8103833 A SE8103833 A SE 8103833A SE 8103833 A SE8103833 A SE 8103833A SE 449816 B SE449816 B SE 449816B
Authority
SE
Sweden
Prior art keywords
spermicidal
groups
composition
composition according
absorbency
Prior art date
Application number
SE8103833A
Other languages
English (en)
Swedish (sv)
Other versions
SE8103833L (sv
Inventor
G Gazzani
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of SE8103833L publication Critical patent/SE8103833L/xx
Publication of SE449816B publication Critical patent/SE449816B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Reproductive Health (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
SE8103833A 1980-06-20 1981-06-18 Vattenfri spermiedodande komposition SE449816B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22910/80A IT1131833B (it) 1980-06-20 1980-06-20 Eccipienti per sostanze spermicide

Publications (2)

Publication Number Publication Date
SE8103833L SE8103833L (sv) 1981-12-21
SE449816B true SE449816B (sv) 1987-05-25

Family

ID=11201796

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8103833A SE449816B (sv) 1980-06-20 1981-06-18 Vattenfri spermiedodande komposition

Country Status (16)

Country Link
US (1) US4371518A (nl)
JP (1) JPS5731607A (nl)
AT (1) AT390882B (nl)
AU (1) AU546430B2 (nl)
BE (1) BE889146A (nl)
CA (1) CA1148861A (nl)
CH (1) CH650156A5 (nl)
DE (1) DE3123823C2 (nl)
DK (1) DK158034C (nl)
FR (1) FR2484838A1 (nl)
GB (1) GB2078110B (nl)
IT (1) IT1131833B (nl)
NL (1) NL187893C (nl)
PH (1) PH16868A (nl)
SE (1) SE449816B (nl)
ZA (1) ZA813735B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1331559C (en) 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
IT1213323B (it) * 1986-08-07 1989-12-20 Crinos Industria Farmaco Composizione per uso locale ad atti vita' spermicida virulicida ,disinfettante e/o battericida
DK89592D0 (da) * 1992-07-07 1992-07-07 Helle Broendsted Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf
ZA947572B (en) * 1993-09-29 1995-09-28 Hampton Roads Medical College Contraceptive compositions
DE69424793T2 (de) * 1993-09-29 2000-09-21 Integra Lifesciences I, Ltd. Empfängnisverhütende zusammensetzungen
WO2004075854A2 (en) * 2003-02-26 2004-09-10 Program For Appropriate Technology In Health Microbicidal compositions and method of use
WO2004105662A1 (en) * 2003-05-23 2004-12-09 Program For Appropriate Technology In Health Microbicidal compositions and methods of use
EP1654348A4 (en) * 2003-08-14 2008-02-13 Bio Balance Corp BACTERIAL STRAINS, COMPOSITIONS AND PROBIOTIC USE THEREOF
UA93354C2 (ru) 2004-07-09 2011-02-10 Гилиад Сайенсиз, Инк. Местный противовирусный препарат
KR20120099473A (ko) 2009-12-01 2012-09-10 세프록스 바이오텍, 에스.엘. Ｈｉｖ 감염 예방을 위한 히드록시타이로졸 및 유도체의 국소적 사용
EP2546358A1 (en) 2011-07-15 2013-01-16 Laboratorios Del. Dr. Esteve, S.A. Methods and reagents for efficient control of HIV progression
EP2606897A1 (en) 2011-12-22 2013-06-26 Laboratorios Del. Dr. Esteve, S.A. Methods and compositions for the treatment of diseases caused by enveloped viruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL255047A (nl) * 1959-08-21
JPS4113117Y1 (nl) * 1964-07-20 1966-06-21
JPS4113118Y1 (nl) * 1964-09-26 1966-06-21
JPS5025744U (nl) * 1973-07-12 1975-03-25
US4242359A (en) * 1977-04-01 1980-12-30 Cornell Research Foundation, Inc. Spermicidal agents
JPS5592312A (en) * 1978-12-29 1980-07-12 Yamanouchi Pharmaceut Co Ltd Suppository containing bronchodilating compound
US4187286A (en) * 1979-01-02 1980-02-05 G&W Laboratories, Inc. Contraceptive suppository
SE431937B (sv) * 1979-01-29 1984-03-12 Perstorp Ab Salicylazosulfapyridinhaltigt medicinskt preparat
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat

Also Published As

Publication number Publication date
GB2078110A (en) 1982-01-06
NL187893B (nl) 1991-09-16
CH650156A5 (it) 1985-07-15
DK158034C (da) 1990-08-13
IT8022910A0 (it) 1980-06-20
GB2078110B (en) 1984-05-16
JPS5731607A (en) 1982-02-20
SE8103833L (sv) 1981-12-21
DE3123823C2 (de) 1987-01-02
JPH0371403B2 (nl) 1991-11-13
AU7165181A (en) 1981-12-24
BE889146A (fr) 1981-10-01
DE3123823A1 (de) 1982-04-22
US4371518A (en) 1983-02-01
PH16868A (en) 1984-03-26
CA1148861A (en) 1983-06-28
IT1131833B (it) 1986-06-25
DK270181A (da) 1981-12-21
ZA813735B (en) 1982-06-30
FR2484838B1 (nl) 1985-05-03
FR2484838A1 (fr) 1981-12-24
AU546430B2 (en) 1985-08-29
NL8102675A (nl) 1982-01-18
DK158034B (da) 1990-03-19
AT390882B (de) 1990-07-10
ATA272181A (de) 1990-01-15
NL187893C (nl) 1992-02-17

Similar Documents

Publication Publication Date Title
SE449816B (sv) Vattenfri spermiedodande komposition
DE2755505C2 (de) Mittel für die verzögerte Abgabe eines biologischen Wirkstoffs
JP2845325B2 (ja) 長時間持続性の避任用坐薬組成物および使用方法
Garg et al. Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent
Sherwood et al. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes
EP1996209B1 (en) Contraceptive composition
SE442167B (sv) Lagringsstabilt prostaglandin innehallande medicinskt preparat
NS Histochemical studies of nephrotoxicity with sublethal doses of mercury in rats.
Moyer et al. Reactions of human endometrium to the intrauterine device: I. Correlation of the endometrial histology with the bacterial environment of the uterus following short-term insertion of the IUD
Lolley et al. ALTERATIONS IN CYCLIC AMP METABOLISM ASSOCIATED WITH PHOTORECEPTOR CELL DEGENERATION IN THE C3H MOUSE 1
CA1216237A (en) Contraceptive composition
Dhondt et al. The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the rabbit vaginal irritation test
Gagné et al. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9
Hottendorf et al. Nonparallel nephrotoxicity dose-response curves of aminoglycosides
JPS6379816A (ja) 局所用法のための組成物
D’Cruz et al. Preclinical evaluation of a dual-acting microbicidal prodrug WHI-07 in combination with vanadocene dithiocarbamate in the female reproductive tract of rabbit, pig, and cat
Andersen et al. A comparison of single‐dose oral fluconazole with 3‐day intravaginal clotrimazole in the treatment of vaginal candidiasis: REPORT OF AN INTERNATIONAL MULTICENTRE TRIAL
Cummings Effect of 5-azacytidine administration during very early pregnancy
Harvey et al. Spermicidal activity of surface-active agents
Boyd et al. Absorption of two trimethoprim/sulphonamide combinations from the uterus of pony mares
Gross et al. A study of suppositorv bases. III. A new water-soluble suppository base
Singh et al. Development And Evaluation Of Novel Aqueous Neem Leaf Extract: A Potent Contraceptive Agent
CN118121621A (zh) 一种抗hpv的外用避孕凝胶及其制备方法
KR100738188B1 (ko) 증류수와 수용성고분자로부터 제조된 피임젤 조성물
Mohsenian et al. Effects of norgestimate in combination with ethinyl estradiol on cervical mucus

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8103833-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8103833-3

Format of ref document f/p: F